Pinnacle Bancorp, Inc. Dexcom Inc Transaction History

Pinnacle Bancorp, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$76.35 - $94.18 $3,588 - $4,426	-47 Reduced 16.32%	241 $19,000
Q2 2022 Jul 12, 2022	BUY	$67.99 - $132.89 $14,685 - $28,704	216 Added 300.0%	288 $21,000
Q3 2021 Oct 12, 2021	SELL	$106.71 - $143.18 $6,509 - $8,733	-61 Reduced 45.86%	72 $39,000
Q4 2019 Jan 10, 2020	SELL	$36.62 - $57.29 $1,208 - $1,890	-33 Reduced 19.88%	133 $29,000
Q3 2019 Oct 08, 2019	BUY	$35.53 - $43.8 $1,172 - $1,445	33 Added 24.81%	166 $25,000
Q4 2018 Mar 20, 2019	BUY	$26.99 - $37.37 $3,589 - $4,970	133 New	133 $16,000

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.